GlassScript(8328) Image Guided Therapy Devices _ Therapy
Payments companies reported to CMS as associated with (8328) Image Guided Therapy Devices _ Therapy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (8328) Image Guided Therapy Devices _ Therapy, per program year, as reported to CMS.
Who makes it
- Philips Electronics North America Corporation $32K associated with (8328) Image Guided Therapy Devices _ Therapy (2023-2025)
- Philips North America LLC $12K associated with (8328) Image Guided Therapy Devices _ Therapy (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (8328) Image Guided Therapy Devices _ Therapy
These are the largest totals companies reported as associated with (8328) Image Guided Therapy Devices _ Therapy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jimmy Kerrigan | Nashville, TN | Interventional Cardiology | $10,000.00 |
| Steven Elias | Englewood, NJ | Vascular Surgery | $7,500.00 |
| David Riggio | Scottsdale, AZ | Clinical Cardiac Electrophysiology | $6,000.00 |
| Brittany Fuller | Detroit, MI | Interventional Cardiology | $4,950.00 |
| Matthew Chung | Richmond, VA | Interventional Cardiology | $4,428.67 |
| Matthew Holland | Denver, CO | Interventional Cardiology | $4,230.00 |
| Rayji Tsutsui | Cleveland, OH | $1,600.00 | |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $1,527.50 |
| Christopher Healy | Indianapolis, IN | Cardiovascular Disease | $1,410.00 |
| Erin Murphy | Charlotte, NC | Vascular Surgery | $650.00 |
Prescribed (8328) Image Guided Therapy Devices _ Therapy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.